Impact Factor
3.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.00
733 total citations
h5-index
30
h5 depth signal
Cited share
88.8%
135 of 152
Total citations
733
Citation footprint
Metric signal
5.44
External metric anchor
Self-citation
4.2%
31 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
572
United Kingdom
94
Canada
39
France
35
Australia
31
Citing Fields of Research
Cancer & Development
107
Genetics & Genomics
101
Cancer, Autophagy & Apoptosis
82
Oncology
72
Neurodegenerative Disorders
70
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,345
Articles tracked across the journal lifetime
Indexed publication set
152
135 cited publications
Last 12 months
36
3.6 publications/month
Open access share
2.8%
1 OA publications in the last year
Leading citing country
United States
572 citing publications
Leading citing field
Cancer & Development
107 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 2011-
v1n1, Sept. 2011-
Active Coverage
Research Focus & Classification
Indexed Subjects
Mycobacterial Diseases
Neurodegenerative Disorders
Diabetes
Cancer, Autophagy & Apoptosis
Immunology
Issuing & Sponsoring Bodies
Contributor
Cold Spring Harbor Laboratory. Press
Broad Categories
Medicine
Cancer, Autophagy & Apoptosis
Diabetes
Cancer & Development
Ophthalmology
Neurodegenerative Disorders
MeSH Descriptors
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1101/cshperspect.a041953
Open DOI
What's New Is Old: “Cultural Lag” and Governance of Risk in the Life Sciences
02
DOI 10.1101/cshperspect.a041804
Open DOI
Clinical Tuberculosis: Presentation and Diagnostic Approach
Tuberculosis (TB) in adults can present in multiple ways. The lung is the most common site of disease, with cough, hemoptysis, weight loss, and night sweats as the most frequent symptoms. Extrapulmonary involvement, which may present man...
03
DOI 10.1101/cshperspect.a041822
Open DOI
Pharmacological Principles in the Use and Development of Antituberculosis Drugs
04
DOI 10.1101/cshperspect.a041887
Open DOI
Post-Tuberculosis Lung Disease: Clinical Spectrum, Management Principles, and Lifelong Consequences
05
DOI 10.1101/cshperspect.a041852
Open DOI
Asymptomatic Tuberculosis: Prevalence, Relevance, Biology, Diagnosis, and Treatment
06
DOI 10.1101/cshperspect.a041825
Open DOI
Transmission and Institutional Infection Control of TB—A Reexamination of Fundamental Strategies
07
DOI 10.1101/cshperspect.a041890
Open DOI
Aerobiology and Transmission of Mycobacterium tuberculosis
08
DOI 10.1101/cshperspect.a041859
Open DOI
New Malaria Prevention Modalities: Long-Acting Interventions Beyond Vaccines
Malaria prevention is key for protecting high-risk groups, such as children and pregnant women. Existing approaches, including insecticide-based vector control, infant vaccination, and targeted chemoprevention are successful in some cont...
09
DOI 10.1101/cshperspect.a041894
Open DOI
The Interaction between Diabetes Mellitus and Tuberculosis: Epidemiology, Screening, and Clinical Management
Tuberculosis (TB) is usually a preventable and curable disease, yet it remains the leading cause of death due to an infectious agent. Diabetes mellitus (DM) is a chronic metabolic disorder with ∼589 million adults living with it worldwid...
10
DOI 10.1101/cshperspect.a041857
Open DOI
The Biology of Malaria Parasite Liver Infection
The Plasmodium liver stages of infection-initiated when mosquito-transmitted sporozoites invade hepatocytes-are asymptomatic and essential for initial parasite replication and progression to blood stage infection. This paper provides an ...
Bibliographical & Catalog Notes
Vol. 1, issue 1 (Sept. 2011) called also "preview issue".